ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Frequently asked questions
What sector does ZSTK (ZSTK) operate in?
ZSTK belongs to the Consumer Staples sector and operates in the Asset Management industry.
What is ZSTK (ZSTK) current stock price?
As of the latest data, ZSTK stock price is $3.13, with a previous close of $3.28. ZSTK lost -$0.15 in the last trading session, representing a -4.57% loss.
What is ZSTK (ZSTK) current market capitalization?
ZSTK market cap is approximately 68.23 million.
What is ZSTK (ZSTK) Earnings Per Share (EPS)?
The trailing EPS is -$42.43.
What is ZSTK (ZSTK) EBITDA?
ZSTK EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.06 million.
Does ZSTK (ZSTK) pay dividends?
No. ZSTK does not pay a dividend.
How did ZSTK (ZSTK) perform in its most recent earnings report?
In the last report (June 30, 2026), ZSTK posted an EPS surprise of -2,145.45% and a revenue surprise of 87.1%.
When is ZSTK (ZSTK) next earnings report?
ZSTK is expected to release its next earnings report on September 30, 2026.
What is ZSTK (ZSTK) beta (volatility) score?
ZSTK has a beta of 1.934, suggesting it is more volatile than the market.
